Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Sep;9(5):534-539.
doi: 10.1016/j.jgo.2018.02.007. Epub 2018 Mar 9.

Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers

Erika Ramsdale  1 , Tatyana Lemelman  2 , Kah Poh Loh  2 , Marie Flannery  2 , Lee Kehoe  2 , Teraisa Mullaney  2 , Megan Wells  2 , Nikesha Gilmore  2 , Sandy Plumb  2 , Supriya Mohile  2
Affiliations
Randomized Controlled Trial

Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers

Erika Ramsdale et al. J Geriatr Oncol. 2018 Sep.

Abstract

Objectives: Polypharmacy (PP) and potentially inappropriate medications (PIM) are common in older adults with cancer, increasing the risk of adverse outcomes. Approaches to identifying and addressing PP/PIM are needed.

Materials and methods: Patients ≥70 years with advanced cancer were enrolled in this cluster-randomized study. All underwent geriatric assessment (GA), and oncologists randomized to the intervention arm received GA-driven recommendations; no information was provided to oncologists at usual care sites. For patients with PP (≥5 medications or ≥1 high-risk medication), clinic visits with treating oncologists were audiorecorded and transcribed, and discussions regarding PP/PIM identified. Quality of provider response was coded as dismissed, mentioned, acknowledged, or addressed.

Results: Forty patient transcripts were analyzed (20 per arm). More discussions occurred in the intervention group (n = 81) versus the usual care group (n = 51). More concerns per patient were brought up in the intervention group (4.1 vs. 2.6, p = 0.07). Physician-initiated discussions were higher in the intervention group (73% vs. 49%, p = 0.006). More PP concerns were "addressed" in the intervention group (59% vs. 45%, p = 0.1). Oncology supportive care medication concerns were more often addressed in the usual care group (58% vs. 18%, p = 0.008), but medication management concerns were addressed more commonly in the intervention group (38% vs. 79%, p = 0.003).

Conclusion: In this secondary analysis, a GA-driven intervention increased PP discussions, particularly about total number of medications and medication management. PP/PIM concerns were more commonly addressed in the intervention group, except for the subset of conversations about supportive care medications.

Keywords: Geriatric assessment; Polypharmacy.

PubMed Disclaimer

Conflict of interest statement

Disclosures and Conflict of Interest Statements

The authors have declared no conflicts of interest.

Figures

Figure 1
Figure 1
Polypharmacy Concerns Discussed by Group.
Figure 2
Figure 2
Initiation of Polypharmacy Concerns.
Figure 3
Figure 3
Quality of Responses to Polypharmacy Concerns.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Salive ME. Multimorbidity in older adults. Epidemiol Rev. 2013;35:75–83. - PubMed
    1. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57–65. - PMC - PubMed
    1. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315:1096–9. - PMC - PubMed
    1. Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005;165:68–74. - PubMed
    1. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27:2758–65. - PubMed

Publication types